← Leaderboards
Philip M Potter
St. Jude Children'S Research Hospital
$7,971,270
Attributed
$8,381,876
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $869.2K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,381,876 · 6
By mechanism
R01$8,381,876 · 6
Top collaborators
- Anang A Shelat2 shared
Others in their field
Top investigators on “Carboxylic Ester Hydrolases”
- Eugene C. Somoza · University Of Cincinnati$3,584,865
- Bill Basinger · Countervail Corporation$2,803,264
- Paul R Carlier · Virginia Polytechnic Inst And St Univ$2,792,091
- Matthew Redinbo · Univ Of North Carolina Chapel Hill$2,626,547
- Karen S Aboody · Layton Bioscience, Inc.$2,625,304
- Yanqiao Zhang · Northeast Ohio Medical University$2,431,324
Research focus
Carboxylic Ester HydrolasesProdrugsAnimal ModelPharmaceutical PreparationsEsteraseCarboxylesteraseBiochemicalInhibitor/AntagonistIn VitroBaseGene ExpressionDesignNeoplasm /Cancer ChemotherapyEnzymesMetabolismHydrolysisPoisonsMouse ModelDrug MetabolismEnzyme InhibitionBiologicalIn VivoSmall MoleculeSn-38
Grant awards (29)
Bromodomain-selective inhibitors for cancer therapy$410,606
R01 · FY2020 · CA · contact PI
Bromodomain-selective inhibitors for cancer therapy$410,606
R01 · FY2019 · CA · contact PI
Modulation of drug metabolism by Danshen$437,500
R01 · FY2016 · AT · contact PI
Modulation of drug metabolism by Danshen$424,375
R01 · FY2015 · AT · contact PI
Modulation of drug metabolism by Danshen$424,375
R01 · FY2014 · AT · contact PI
Modulation of drug metabolism by Danshen$415,625
R01 · FY2013 · AT · contact PI
Selective inhibitors to improve CPT-11 therapy$295,463
R01 · FY2013 · CA · contact PI
Selective inhibitors to improve CPT-11 therapy$314,323
R01 · FY2012 · CA · contact PI
Selective inhibitors to improve CPT-11 therapy$314,323
R01 · FY2011 · CA · contact PI
Selective inhibitors to improve CPT-11 therapy$324,045
R01 · FY2010 · CA · contact PI
Novel Therapeutic Approaches for Narcotic Overdose$273,051
R01 · FY2009 · DA · contact PI
Novel Therapeutic Approaches for Narcotic Overdose$273,888
R01 · FY2008 · DA · contact PI
Selective Inhibitors to Improve CPT-11 Therapy$243,446
R01 · FY2008 · CA · contact PI
Novel Therapeutic Approaches for Narcotic Overdose$277,770
R01 · FY2007 · DA · contact PI
Selective Inhibitors to Improve CPT-11 Therapy$243,446
R01 · FY2007 · CA · contact PI
SELECTIVE THERAPY OF TUMORS THAT OVEREXPRESS C MYC$293,316
R01 · FY2006 · CA · contact PI
Novel Therapeutic Approaches for Narcotic Overdose$289,142
R01 · FY2006 · DA · contact PI
Selective Inhibitors to Improve CPT-11 Therapy$250,717
R01 · FY2006 · CA · contact PI
Novel Therapeutic Approaches for Narcotic Overdose$303,750
R01 · FY2005 · DA
SELECTIVE THERAPY OF TUMORS THAT OVEREXPRESS C MYC$300,375
R01 · FY2005 · CA
Selective Inhibitors to Improve CPT-11 Therapy$265,045
R01 · FY2005 · CA
SELECTIVE THERAPY OF TUMORS THAT OVEREXPRESS C MYC$300,375
R01 · FY2004 · CA
SELECTIVE THERAPY OF TUMORS THAT OVEREXPRESS C MYC$300,375
R01 · FY2003 · CA
SELECTIVE THERAPY OF TUMORS THAT OVEREXPRESS C MYC$299,875
R01 · FY2002 · CA
SELECTIVE THERAPY OF NEUROBLASTOMA$190,864
R01 · FY2002 · CA
SELECTIVE THERAPY OF NEUROBLASTOMA$22,451
R01 · FY2002 · CA
SELECTIVE THERAPY OF NEUROBLASTOMA$185,307
R01 · FY2001 · CA
SELECTIVE THERAPY OF NEUROBLASTOMA$169,495
R01 · FY2000 · CA
SELECTIVE THERAPY OF TUMORS THAT OVEREXPRESS C MYC$127,947
R01 · FY2000 · CA